Aptinyx Inc - ESG Rating & Company Profile powered by AI
This report of Aptinyx Inc was assembled by All Street Sevva using proprietary machine learning. The dashboard contains a Q&A table about Aptinyx Inc. The webpage contains a zero-cost E,S&G report for Aptinyx Inc.
Aptinyx Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.3; made up of an environmental score of 0.0, social score of 0.0 and governance score of 4.0.
1.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1747 | Sinphar Pharmaceutical Co Ltd | 1.4 | Low |
| 1747 | WooGene B&G Co Ltd | 1.4 | Low |
| 1755 | Aptinyx Inc | 1.3 | Low |
| 1755 | Cheng Du Sheng Nuo Biotec Co Ltd | 1.3 | Low |
| 1755 | ALX Oncology Holdings Inc | 1.3 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Aptinyx Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Aptinyx Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Aptinyx Inc report the average age of the workforce?
Sign up for free to unlockDoes Aptinyx Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Aptinyx Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Aptinyx Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Aptinyx Inc offer flexible work?
Sign up for free to unlockDoes Aptinyx Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Aptinyx Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Aptinyx Inc conduct supply chain audits?
Sign up for free to unlockDoes Aptinyx Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Aptinyx Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Aptinyx Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Aptinyx Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Aptinyx Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Aptinyx Inc disclose water use targets?
Sign up for free to unlockDoes Aptinyx Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Aptinyx Inc have a product recall in the last two years?
Sign up for free to unlockDoes Aptinyx Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Aptinyx Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Aptinyx Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Aptinyx Inc disclose parental leave metrics?
Sign up for free to unlockDoes Aptinyx Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Aptinyx Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Aptinyx Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Aptinyx Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Aptinyx Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Aptinyx Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Aptinyx Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Aptinyx Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Aptinyx Inc disclose its waste policy?
Sign up for free to unlockDoes Aptinyx Inc report according to TCFD requirements?
Sign up for free to unlockDoes Aptinyx Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Aptinyx Inc disclose energy use targets?
Sign up for free to unlockDoes Aptinyx Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Aptinyx Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Aptinyx Inc
These potential risks are based on the size, segment and geographies of the company.
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II/b clinical trial for treating fibromyalgia. It is also developing NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase II/b clinical trial to treat post-traumatic stress disorder; and NYX-458, an NMDAr modulator, which is in Phase II clinical study for the treatment of Parkinson's disease cognitive impairment. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.